HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jin, R. Articles by Waddell, T. K. Search for Related Content PubMed PubMed Citation Articles by Jin, R. Articles by Waddell, T. K.

Human Monocytes Recognize Porcine Endothelium via the Interaction of Galectin 3 and -GAL¹

Rongyu Jin^*, Allen Greenwald^*, Mark D. Peterson and Thomas K. Waddell^2,*,

^* Division of Thoracic Surgery, Department of Surgery, Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada; and Division of Cardiac Surgery, Department of Surgery, Toronto General Hospital Research Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada

Monocytes are one of the key inflammatory cells recruited to xenografts and play an important role in delayed xenograft rejection. Previous studies have demonstrated the ability of monocytes to bind to the major xenoantigen Gal-(1,3)Gal-(1,4)GlcNAc-R; however, the receptor that mediates this interaction has yet to be identified. We provide evidence that it is Galectin-3, a 30-kDa lectin that recognizes -galactosides (Gal-(1–3/4)GlcNAc) and plays diverse roles in many physiological and pathological events. Human monocyte binding is strikingly increased on porcine aortic endothelial cells (PAEC), which express high levels of Gal-(1,3)Gal-(1,4)GlcNAc-R, compared with human aortic endothelial cells. Human monocytes obtained from healthy donors bind to Gal-(1,3)Gal-(1,4)GlcNAc-R at variable intensities. This variation of binding intensity was consistent and reproducible in individual donors. Galectin-3 is mainly expressed in human monocytes, not lymphocytes. Purified Galectin-3 is able to bind directly to Gal-(1,3)Gal-(1,4)GlcNAc-R. Galectin-3 can also be affinity isolated from monocytes (and not lymphocytes) using an Gal-(1,3)Gal-(1,4)GlcNAc-R-biotin/streptavidin-bead pull-down system. Soluble Galectin-3 binds preferentially to PAEC vs human aortic endothelial cells, and this binding can be inhibited by lactose, indicating dependence on the carbohydrate recognition domain of Galectin-3. Gal-(1,3)Gal-(1,4)GlcNAc-R is at least partly responsible for this phenomenon, as binding decreased after digestion of PAEC with -galactosidase. Furthermore, monocytes pretreated with a blocking anti-Galectin-3 Ab show decreased adhesion to PAEC when compared with isotype control in a parallel plate flow chamber perfusion assay. Thus, we conclude that Galectin-3 expressed in human monocytes is a receptor for the major xenoantigen (Gal-(1,3)Gal-(1,4)GlcNAc-R), expressed on porcine endothelial cells.

This article has been cited by other articles:

				K. J. POSEKANY, J. E. WILEY, and G. A. GAGNON A Novel Method to Display [gal {alpha}1, 3 gal] Antigens on Human Leukemic Cells for Preparation of Anti-leukemia Vaccines Anticancer Res, June 1, 2009; 29(6): 2387 - 2392. [Abstract] [Full Text] [PDF]

				E. M Rapoport, S. Andre, O. V Kurmyshkina, T. V Pochechueva, V. V Severov, G. V Pazynina, H.-J Gabius, and N. V Bovin Galectin-loaded cells as a platform for the profiling of lectin specificity by fluorescent neoglycoconjugates: A case study on galectins-1 and -3 and the impact of assay setting Glycobiology, April 1, 2008; 18(4): 315 - 324. [Abstract] [Full Text] [PDF]

				K. Ide, H. Wang, H. Tahara, J. Liu, X. Wang, T. Asahara, M. Sykes, Y.-G. Yang, and H. Ohdan Role for CD47-SIRP{alpha} signaling in xenograft rejection by macrophages PNAS, March 20, 2007; 104(12): 5062 - 5066. [Abstract] [Full Text] [PDF]